AI could predict which prostate cancers turn aggressive

NCT ID NCT07658573

Ongoing Knowledge-focused Sponsor: Guangxi Medical University Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study is developing an artificial intelligence model to predict which patients with advanced prostate cancer are at higher risk of developing a more severe form called castration-resistant prostate cancer. The AI will analyze MRI images, biopsy slides, and clinical data from over 500 patients who received hormone therapy or surgery. The goal is to help doctors identify high-risk patients earlier and personalize treatment plans.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Artificial intelligence model
What this could lead to: If successful, this AI could help doctors identify high-risk patients earlier and tailor treatments to improve outcomes.
What could go wrong: This is a retrospective study, not a clinical trial testing a new treatment. The AI model may not perform as well in real-world settings.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CASTRATION-RESISTANT PROSTATE CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

castration-resistant prostate carcinoma prostate cancer

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CASTRATION-RESISTANT PROSTATE CANCER PROSTATE CANCER

Contacts and locations

Locations

Guangxi Medical University First Affiliated Hospital

Nan'ning, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.